Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescent detection with methyl aminolevulinate in basal cell carcinoma vs Mohs margins
2005-005769-12Phase 4Completed
- Sponsor
- Galderma
- Start
- Apr 2006
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methyl aminolevulinate in basal cell carcinoma (BCC), sponsored by Galderma. Started Apr 2006; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2005-005769-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005769-12.